Abstract
BACKGROUND CONTEXT: Lumbar degenerative disc disease is universal and spinal fusion has been the traditional surgical gold standard treatment for intractable pain due to degenerative disc disease. Concerns with fusion morbidity, prolonged recovery and accelerated adjacent segment degeneration have led researchers to develop motion-preserving artificial disc replacement (ADR) as alternative to fusion. ProDisc-L™ (Synthes Spine, West Chester, PA) is an ADR that has been approved by the FDA with recent prospective randomized control trial (PRCT) documented results demonstrating superior outcomes in one level ADR patients compared with circumferential fusion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
